Both the World Health Organization and Eli Lilly warned Thursday that consumers should avoid fake versions of weight-lossThe WHO warning said that the international health agency has fielded several reports of fake semaglutide -- the active ingredient in Novo Nordisk's Wegovy and Ozempic -- in all geographic regions of the world since 2022.
“WHO advises healthcare professionals, regulatory authorities and the public be aware of these falsified batches of medicines,” Dr. Yukiko Nakatani, WHO Assistant Director-General for Access to Medicines and Health Products, said in the warning. “We call on stakeholders to stop any usage of suspicious medicines and report to relevant authorities.”
Meanwhile, Lilly said in an open letter that it was “deeply concerned” about phony or compounded versions of tirzepatide, the active ingredient in the Lilly weight-loss"These products are often advertised and sold online, through social media or at certain med-spas," Lilly said in its letter. "They may contain no medicine, the wrong medicine, incorrect dosages or multiple medicines mixed together, which could result in serious harm. They are never safe to use.
For its part, Lilly noted any products marketed as tirzepatide and not Mounjaro or Zepbound were not made by the drugmaker and are not approved for use by the U.S. Food and Drug Administration.Copyright © 2024 HealthDay. All rights reserved.
Source: Healthcare Press (healthcarepress.net)
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: fox32news - 🏆 547. / 51 Read more »
Source: ABC - 🏆 471. / 51 Read more »
Swimmer Lilly King Qualifies for Olympics and Gets Surprise Proposal From BoyfriendAn incredible moment for Lilly King.
Source: SInow - 🏆 273. / 63 Read more »
Source: NBCLA - 🏆 319. / 59 Read more »
Source: ksatnews - 🏆 442. / 53 Read more »
Source: KPRC2 - 🏆 80. / 68 Read more »